India & United States — Food and Drug Administration
7 shared events · Importance 9 · Last updated Jun 15, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Business
India: India will benefit from increased access to advanced multi-cancer detection screening, potentially improving public health outcomes by enabling earlier diagnosis and treatment of various cancers.
United States — Food and Drug Administration: The United States — Food and Drug Administration granted Breakthrough Device Designation to the Shield Multi-Cancer Detection test, recognizing its potential, though this does not imply regulatory approval or clearance.
Jul 03, 2026 · 6 articles
NEWSDESK
Explore this relationship live
Track how India and United States — Food and Drug Administration interact across events, view sentiment trends, and discover connected entities.
Open Dashboard